Aclaris Therapeutics, Inc.

Q4 2021 13F Holders

Symbol
ACRS
CUSIP
00461U105
Type
Equity
Class
COM
Num filings
140
Total reported value, excl. options
$828 M
Manager Report Date Value ($000) Shares Option Type